Ethnic misclassifications hamper progress in researchBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7553.1335 (Published 01 June 2006) Cite this as: BMJ 2006;332:1335
- Charles Agyemang (firstname.lastname@example.org), associate researcher
- Amsterdam Medical Centre, Department of Social Medicine, 1100 DD, Amsterdam
EDITOR—McDowell et al review the evidence for ethnic differences in susceptibility to adverse drug reactions to cardiovascular drugs.1 They concluded that patients from different ethnic groups have different risks for adverse reactions to cardiovascular drugs and that ethnic group may be one determinant of harms of a given treatment, either because it acts as a surrogate measure …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial